NCT05354505View on ClinicalTrials.gov

Fetal Endoscopic Tracheal Occlusion (FETO) Trial for Congenital Diaphragmatic Hernia (CDH)

NARecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2027

Conditions
Diaphragmatic Hernia
Interventions
DEVICE

Placement of the GOLDBAL2 balloon

The Fetal Endoscopic Tracheal Occlusion (FETO) procedure using the Goldballoon Detachable Balloon (GOLDBAL2) along with the Delivery Microcatheter (BALTACCI-BDPE100) will be used to treat fetuses diagnosed with severe Congenital Diaphragmatic Hernia (CDH)

Trial Locations (1)

11021

RECRUITING

Columbia University Irving Medical Center/NewYork-Presbyterian, New York

All Listed Sponsors
lead

Vincent Duron

OTHER

NCT05354505 - Fetal Endoscopic Tracheal Occlusion (FETO) Trial for Congenital Diaphragmatic Hernia (CDH) | Biotech Hunter | Biotech Hunter